netFormulary

Lancashire and South Cumbria
Formulary

4 Central nervous system

This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.

For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/

04-09-01 Dopamine receptor agonists

Apomorphine APO-go^®, Dacepton^®

Formulary

Injection 50mg/5mL

Pre-filled pen 30mg/3mL

LSCMMG: Shared care guideline

MHRA: Apomorphine with domperidone: minimising risk of cardiac side effects

Pramipexole

Formulary

Tablets 88micrograms, 180micrograms, 350 micrograms, 700micrograms pramipexole base (equivalent to 125micrograms, 250micrograms, 500micrograms and 1mg pramipexole salt)
m/r tablets 260 micrograms, 520 micrograms 1.05mg, 2.1mg, 3.15mg base (equivalent to 375micrograms, 750micrograms, 1.5mg, 3mg, 4.5mg salt)

Pramipexole (first line) and ropinirole (second line) are Green Traffic Light for moderate to severe restless legs syndrome - see prescribing guideline

LSCMMG: The Management of Restless Legs Syndrome in Adults in Primary Care

Ropinirole

Formulary

Tablets 250micrograms, 1mg, 2mg, 5mg
m/r tablets 2mg, 4mg, 8mg

Please prescribe Ropinirole m/r 2mg, 4mg and 8mg as the branded generic Ipinnia XL® in primary care

Pramipexole (first line) and ropinirole standard release tablets (second line) are Green Traffic Light for moderate to severe restless legs syndrome - see prescribing guideline

Rotigotine

Formulary

Patch 2mg, 4mg, 6mg, 8mg

Links